Return to content in this issue

Pilot Experience Using Drug Provocation Testing for the Study of Hypersensitivity to Chemotherapy and Biological Agents

Martí-Garrido J^1,2, Vázquez-Revuelta P^1,2, Lleonart-Bellfill R^1,2, Molina-Mata K^1,3, Muñoz-Sánchez C^1,4, Madrigal-Burgaleta R<sup>1,5

1</sup>Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain
²Allergy Service, Internal Medicine Department, Bellvitge University Hospital, Barcelona, Spain
³Medical Oncology Service, Catalan Institute of Oncology, Barcelona, Spain
⁴Pharmacy Service, Catalan Institute of Oncology, Barcelona, Spain
⁵Allergy and Severe Asthma Service, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

J Investig Allergol Clin Immunol 2021; Vol 31(2) : 166-168
doi: 10.18176/jiaci.0552

• Abstract
• Supplemental Materials

Key words: Drug allergy, Delabeling, Drug challenge, Desensitization, Skin testing

	Title	Type	Size
	10.18176_jiaci.0552_material-suppl.pdf	pdf	224.88 Kb